Iowa Tech Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Tech Report.

Press releases published on September 9, 2026

Sep. 9, 2026

Melissa Brings Native Change-of-Address Updates to Salesforce

Indeterminate GlobeNewswire

Sep. 9, 2026

Americans warming up to EVs as charging infrastructure confidence grows, HERE-SBD EV Index 2026 finds

Indeterminate GlobeNewswire

Sep. 9, 2026

RemoFirst Launches New Integration with Workday, Reducing Manual HR Data Entry for Global Teams

Indeterminate GlobeNewswire

Sep. 9, 2026

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Medicare Answers Now joins AgencyBloc Partner Program as Preferred Partner and Charter Member

Indeterminate GlobeNewswire

Sep. 9, 2026

SpyCloud 2026 Identity Threat Report Finds Non-Human Identities Are Now the Leading Path into the Enterprise

Indeterminate GlobeNewswire

Sep. 9, 2026

Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

Indeterminate GlobeNewswire

Sep. 9, 2026

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 9, 2026

IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

Indeterminate GlobeNewswire

Sep. 9, 2026

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

AI Claws Signal the Next Phase of Enterprise AI: Persistent, Collaborative Agents

Indeterminate GlobeNewswire

Sep. 9, 2026

NodThera Inc. Changes Name to Rezera Inc. and Announces Ruvonoflast Phase 3 Development Program

Indeterminate GlobeNewswire

Sep. 9, 2026

Aktis Oncology to Present at Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 9, 2026

Starton Therapeutics to Present at the 17th Annual World Bispecific Summit in Boston

Indeterminate GlobeNewswire

Sep. 9, 2026

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

Sep. 9, 2026

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Indeterminate GlobeNewswire

Sep. 9, 2026

Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months

Indeterminate GlobeNewswire

Sep. 9, 2026

Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured

Indeterminate GlobeNewswire